KLRK1 and Parkinson disease: In this assessment, we also analyzed receptor expression profiles within NK cell subsets, including the variable expressions of NKG2D, NKG2A, and CX3CR1 on CD56bright, CD56dim, and CD56− NK subsets which delineated a profile for the subtle changes within these NK cell populations in PD patients.